EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Modulating Neuroinflammation as a Prospective Therapeutic Target in Alzheimer’s Disease

Eunshil Lee, Yongmin Chang

Cells · 22.01.2025 · 14 (3) · 168

DOI: 10.3390/cells14030168 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 22.01.2025. Verfasst von Eunshil Lee und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedical Engineering Research, Kyungpook National University, Daegu 41944, Republic of Korea. Hauptthemen laut MEDLINE: Alzheimer Disease, Neuroinflammatory Diseases, Inflammation. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 296 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Korea Dementia Research Center (KDRC), funded by the Ministry of Health & Welfare and Ministry of Science and ICT, Republic of Korea, National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The recent approval of lecanemab highlights that the amyloid beta (Aβ) protein is an important pathological target in Alzheimer’s disease (AD) and further emphasizes the significance of neuroinflammatory pathways in regulating Aβ accumulation. Indeed, Aβ accumulation triggers microglia activation, which are key mediators in neuroinflammation. The inflammatory responses in this process can lead to neuronal damage and functional decline. Microglia secrete proinflammatory cytokines that accelerate neuronal death and release anti-inflammatory cytokines and growth factors contributing to neuronal recovery and protection. Thus, microglia play a dual role in neurodegeneration and neuroprotection, complicating their function in AD. Therefore, elucidating the complex interactions between Aβ protein, microglia, and neuroinflammation is essential for developing new strategies for treating AD. This review investigates the receptors and pathways involved in activating microglia and aims to enhance understanding of how these processes impact neuroinflammation in AD, as well as how they can be regulated. This review also analyzed studies reported in the existing literature and ongoing clinical trials. Overall, these studies will contribute to understanding the regulatory mechanisms of neuroinflammation and developing new therapies that can slow the pathological progression of AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseNeuroinflammatory DiseasesInflammationHumansMicrogliaAnimalsAmyloid beta-Peptides

Stichwörter der Autor:innen

Alzheimer’s diseasemicroglianeuroinflammationpathwaysreceptors

Substanzen

Amyloid beta-Peptides

Autor:innen und Institutionen

  • Institute of Biomedical Engineering Research, Kyungpook National University, Daegu 41944, Republic of Korea.
  • Department of Molecular Medicine, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea.
  • Department of Radiology, Kyungpook National University Hospital, Daegu 41944, Republic of Korea.

Förderung

  • the Korea Dementia Research Center (KDRC), funded by the Ministry of Health & Welfare and Ministry of Science and ICT, Republic of Korea
  • National Research Foundation of Korea

Zitieren

APA

Lee, E., & Chang, Y. (2025). Modulating Neuroinflammation as a Prospective Therapeutic Target in Alzheimer’s Disease. Cells, 14(3), 168. https://doi.org/10.3390/cells14030168

Vancouver

Lee E, Chang Y. Modulating Neuroinflammation as a Prospective Therapeutic Target in Alzheimer’s Disease. Cells. 2025;14(3):168. doi:10.3390/cells14030168

BibTeX
@article{Lee2025,
  author = {Lee, Eunshil and Chang, Yongmin},
  title = {Modulating Neuroinflammation as a Prospective Therapeutic Target in Alzheimer’s Disease},
  journal = {Cells},
  year = {2025},
  volume = {14},
  number = {3},
  pages = {168},
  doi = {10.3390/cells14030168}
}
Kostenlos starten →